… of these studies investigated clopidogrel response. The absence of the polymorphism in the
present … that the inter-individual response to clopidogrel must be influenced by other factors. …

… followed by assessment of the impact of PPIs and polymorphisms on clopidogrel’s efficacy
with … Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009; 360: …

… [ 6 ] Considering the paucity of Indian data regarding the influence of CYP2C19, P2Y12,
and ABCB1 genetic polymorphisms on the antiplatelet effect of clopidogrel, we conducted this …

… the variability in response to clopidogrel explained by the six polymorphisms is poor when
… Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009; 360: …

… platelet inhibition by clopidogrel and high on-treatment platelet aggregation. PON1 (Q192R)
polymorphism does not appear to be a significant determinant of clopidogrel response. …

… impact of CYP2C19 polymorphisms on platelet response after clopidogrel dose adjustment.
… Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009; 360(4): …

… in clopidogrel-induced platelet inhibition, and a substantial proportion of patients will exhibit
non-responsiveness to clopidogrel. … polymorphisms associated with suboptimal clopidogrel-…

… Although polymorphisms of the P2Y 12 receptor have been … clopidogrel response in patients
with CAD. In addition, as the P2Y 12 receptor is the target for both prasugrel and clopidogrel …

… evidence supports some CYP2C19 polymorphisms on clopidogrel efficacy and effectiveness…
6 – 12 h from the administration of clopidogrel to evaluate its response. However, in patients …

… low response to clopidogrel in patients with coronary heart disease is correlated with CYP2C19
gene polymorphism, … in patients undergoing stenting with clopidogrel treatment, which is …